The explosion of available health data is giving organizations the opportunity for the first time to leverage critical data analysis for key services such as financial and clinical decision support management.
This week, a report from Transparency Market Research (TMR) found that the global IT spending on clinical analytics reached $11.6 billion in 2015 and is projected to reach $32.4 billion by 2024.
The high demand of integrated clinical analytics solutions stems from their dynamic nature and ability for users to extract data from clinical documents synched with the system, such as (electronic health records) EHR, using the data to generate key insights, TMR said.
As a result, this spending makes sense when seen as the means to leverage programs offering actionable insight previously unavailable to healthcare leaders, Stefano Bertozzi, dean and professor of health policy and management at the UC Berkeley School of Public Health, said recently in Healthcare IT News.
"But to the extent that we are increasingly able to correct for other factors that create differences, Big Data can reveal what the differences in performance really are," he said. "And, as a result, what are the interventions that are effective for improving the performance."
LUMEDX is leveraging analytics for healthcare leaders to access new insights in key operations. LUMEDX's HealthView Analytics and Cardiovascular Performance Program (CPP) delivers immediate access to the clinical and financial information needed for success in value-based healthcare: registry, outcomes, and risk data; operational data; physician scorecards; and more.
By offering meaningful analytics that enable you to monitor, measure, and improve all aspects of CV services, LUMEDX's data intelligence tools and packages help drive performance while reducing costs.